Shares and Capital Structure

The share capital of Oryzon Genomics, S.A. stands at €1,708,069.55, and is represented by 34,161,391 shares, each with a par value of €0.05, numbered sequentially from 1 through 34,161,391, fully subscribed and paid up.

All the shares are of the same class and series and have the same voting and economic rights.

Oryzon Genomics, S.A.'s shares are currently listed on the Madrid, Barcelona, Bilbao and Valencia stock exchanges via the SIBE electronic trading platform. 

There follows a breakdown of the variations in share capital and shares:
 

Date Event Share Capital (€) Resulting number of shares Resulting nominal value per share (€) Resulting share capital (€)
02/Jun/2000 Initial equity 3,100 310 10 3,100
20/Dec/2001 Changing nominal value and numbering - 3,100 1 3,100
Capital increase 779 3,879 1 3,879
06/Mar/2002 Capital increase 273 4,152 1 4,152
26/Jul/2002 Capital increase 99,648 4,152 25 103,800
20/Nov/2002 Changing nominal value and numbering - 20,760 5 103,800
06/Mar/2003 Capital increase 49,740 30,708 5 153,540
07/May/2004 Capital increase 16,535 34,015 5 170,075
01/Sep/2006 Capital increase 7,865 35,588 5 177,940
27/Dec/2007 Changing nominal value and number - 17,794,000 0.01 177,940
14/Apr/2008 Capital increase 28,500 20,644,000 0.01 206,440
11/Jul/2008 Capital increase 5,200.76 21,164,076 0.01 211,640.76
22/Oct/2009 Capital increase 5,000 21,664,076 0.01 216,640.76
05/Nov/2009 Capital increase 13,176.72 22,981,748 0.01 229,817.48
22/Dec/2011 Capital increase 6,089.98 23,590,746 0.01 235,907.46
30/Dec/2015 Capital increase 707,722.38 23,590,746 0.04 943,629.84
24/Jul/2015 Capital increase 156,342.20 27,499,301 0.04 1,099,972.04
13/Oct/2015 Capital increase 38,741 28,467,826 0.04 1,138,713.04
29/Jun/2016 Capital increase by Changing nominal value 284,678.26 28,467,826 0.05 1,423,391.30
04/Apr/2017 Capital increase 284,678.25 34,161,391 0.05 1,708,069.55
2017 Current Situation - 34,161,391 0.05 1,708,069.55